Showing results (241-250 of 269) with videos related to
Sort By:
Pageof 27
The Biochemical Journal|January 1, 1990
Transient activation of topoisomerase I in leukotriene D4 signal transduction in human cellsM R Mattern, S Mong, S M Mong, et al.Antimicrobial Agents and Chemotherapy|May 1, 1984
Improved genetically modified Escherichia coli strain for prescreening antineoplastic agentsH R Bartus, C K Mirabelli, J I Auerbach, et al.Journal of Medicinal Chemistry|February 1, 1986
Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexesC K Mirabelli, R K Johnson, D T Hill, et al.Cancer Treatment Reports|February 1, 1980
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim reportM D DeFuria, R B Bracken, D E Johnson, et al.Nucleic Acids Research|October 25, 1991
Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infectionG D Hoke, K Draper, S M Freier, et al.Science (New York, N.Y.)|August 14, 1992
Pseudo--half-knot formation with RNAD J Ecker, T A Vickers, T W Bruice, et al.Cancer Research|February 1, 1988
Tumorigenicity of the cyc- variant of the S49 murine lymphoma deficient in the Gs-alpha subunit of adenylate cyclaseJ M Stadel, R K Johnson, C K Mirabelli, et al.The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administrationM J Graham, S T Crooke, D K Monteith, et al.Cancer Treatment Reports|September 1, 1979
Antileukemia (L1210) activity and toxicity of cis-dichlorodiammineplatinum(II) analogsA W Prestayko, W T Bradner, J B Huftalen, et al.Cancer|April 1, 1982
Cyclophosphamide, doxorubicin, vincristine, and low-dose continuous infusion bleomycin in non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study No. 7804S J Ginsberg, S T Crooke, C D Bloomfield, et al.Pageof 27